Invention Grant
- Patent Title: Crystalline forms of a ryanodine receptor modulator and uses thereof
-
Application No.: US17967308Application Date: 2022-10-17
-
Publication No.: US12076327B2Publication Date: 2024-09-03
- Inventor: Pascal Taulelle , Sandro Belvedere
- Applicant: ARMGO Pharma, Inc.
- Applicant Address: US NY Ardsley
- Assignee: ARMGO Pharma, Inc.
- Current Assignee: ARMGO Pharma, Inc.
- Current Assignee Address: US NY Ardsley
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D281/10
- IPC: C07D281/10 ; A61K31/554 ; A61P9/00 ; A61P21/00
Abstract:
The present disclosure relates to crystalline forms of the compound 4-[(7-methoxy-2,3-dihydro-1, 4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, pharmaceutical compositions comprising these compounds and uses thereof to treat diseases and conditions associated with Ryanodine Receptor (RyR) dysfunction, in particular cardiac and musculoskeletal disorders and diseases.
Public/Granted literature
- US20230069022A1 CRYSTALLINE FORMS OF A RYANODINE RECEPTOR MODULATOR AND USES THEREOF Public/Granted day:2023-03-02
Information query
